Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte. (Q40652614)
Jump to navigation
Jump to search
scientific article published on April 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte. |
scientific article published on April 1997 |
Statements
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte (English)
C Gisselbrecht
E Lepage
Y Bastion
H Tilly
A Bosly
B Dupriez
G Marit
E Deconinck
J P Marolleau
A Yver
F Dabouz-Harrouche
B Coiffier
1 April 1997
1 reference
1 reference
1 reference
1 reference